Neurogenic Bladder with Urinary Retention and Elevated Post-Void Residual Urine Volume
This protocol addresses neurogenic lower urinary tract dysfunction (NLUTD) presenting with urinary retention, elevated post-void residual (PVR) urine volume, and detrusor sphincter dyssynergia — a combination that impairs effective bladder emptying and requires a structured management approach.
The patient presents with neurogenic bladder complicated by:
For NLUTD patients who retain the ability to void spontaneously, a specific pharmacological class may be recommended to improve voiding parameters. The complete protocol details which agents apply, under what conditions, and what additional measures address insufficient bladder emptying.
The primary aims of management are a decreased post-void residual urine volume and an increased voided volume.
References
- Clinicians may recommend alpha-blockers to improve voiding parameters in NLUTD patients who spontaneously void.
- Administration of alpha-blockers can decrease PVRs and maximum urethral pressure (MUP) and increase MCC and voided volume; most AEs were minor.